ZFP57 inhibitors represent a category of small molecules or compounds that target the zinc finger protein 57 (ZFP57), a transcription factor involved in the regulation of genomic imprinting and the maintenance of DNA methylation patterns. ZFP57 is a key player in recognizing specific methylated DNA sequences at imprinted loci and recruiting other proteins involved in maintaining epigenetic marks across cell divisions. The zinc finger domains of ZFP57 facilitate the binding to these methylated regions, ensuring that the epigenetic information is stably inherited during mitosis. By inhibiting ZFP57, these molecules disrupt its interaction with DNA, leading to changes in the epigenetic landscape. This can result in altered gene expression patterns, particularly in regions governed by imprinted genes, which are monoallelically expressed depending on the parent of origin.
Research into ZFP57 inhibitors is mainly centered on understanding their role in epigenetic regulation, and their impact on processes such as DNA methylation maintenance and transcriptional control. The study of ZFP57 inhibitors also sheds light on the intricate network of proteins that govern epigenetic marks, such as methyltransferases and demethylases, which collaborate with ZFP57 in maintaining the epigenome. These inhibitors serve as valuable tools for dissecting the molecular mechanisms of imprinting and the broader dynamics of epigenetic regulation. Furthermore, their study contributes to the understanding of how perturbations in the epigenetic machinery can lead to significant biological consequences, providing insight into the fundamental principles of gene regulation and inheritance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108, another DNA methyltransferase inhibitor, may indirectly influence ZFP57 activity by changing DNA methylation patterns, affecting genomic imprinting regulated by ZFP57. | ||||||
SGI-1027 | 1020149-73-8 | sc-473875 | 10 mg | $213.00 | ||
SGI-1027 is a DNA methyltransferase inhibitor that can indirectly modulate ZFP57 function by altering DNA methylation, which is crucial for ZFP57's role in genomic imprinting. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine, a DNA methyltransferase inhibitor, can indirectly affect ZFP57 by modifying DNA methylation patterns, thereby potentially influencing ZFP57-mediated regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, indirectly influences ZFP57 by altering histone acetylation and chromatin structure, which can impact genomic imprinting. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA, a histone deacetylase inhibitor, can indirectly modulate ZFP57 activity through its effects on chromatin acetylation and transcriptional regulation. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat, another HDAC inhibitor, may indirectly influence ZFP57 function by modifying the chromatin landscape and affecting transcriptional regulation. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat, a pan-HDAC inhibitor, can indirectly affect ZFP57 by influencing chromatin structure and gene expression, which are integral to ZFP57's role. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, an HDAC inhibitor, may indirectly impact ZFP57 activity by altering histone acetylation and affecting genomic imprinting processes. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
BIX-01294, a G9a histone methyltransferase inhibitor, can indirectly affect ZFP57 by altering histone methylation, potentially impacting genomic imprinting. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638, another G9a inhibitor, may indirectly modulate ZFP57 function by affecting histone methylation and chromatin architecture. | ||||||